当前位置:首页 - 行情中心 - 康辰药业(603590) - 财务分析

康辰药业

(603590)

  

流通市值:49.66亿  总市值:50.32亿
流通股本:1.57亿   总股本:1.59亿

康辰药业(603590)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.48亿元,每股收益0.28元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益343966.42万元,未分配利润200909.08万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产388516.84万元,负债44550.42万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入212,002,399.05825,397,797.2646,310,729.73405,024,853.01
营业总成本152,416,687.23696,236,061.61518,431,065.74317,146,155.19
营业利润56,852,397.8139,087,805.17144,401,420.69100,932,956.19
利润总额55,550,359.9138,863,747.55144,212,254.67100,804,286.39
净利润48,137,550.3721,530,544.55123,523,551.6687,281,016.36
其他综合收益-38,283,346.8658,297,183.2751,595,510.6518,880,650.61
综合收益总额9,854,203.5179,827,727.82175,119,062.31106,161,666.97
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,192,375,175.061,086,540,037.051,134,614,428.361,111,299,616.69
非流动资产合计2,692,793,179.962,833,148,853.42,861,441,889.752,797,194,088.04
资产总计3,885,168,355.023,919,688,890.453,996,056,318.113,908,493,704.73
流动负债合计312,765,161.81352,683,215.26319,470,870.04354,744,055.56
非流动负债合计132,739,009.6140,841,678.43159,171,916.1122,345,294.73
负债合计445,504,171.41493,524,893.69478,642,786.14477,089,350.29
归属于母公司股东权益合计3,154,272,355.953,144,412,325.673,204,427,809.263,120,888,331.14
股东权益合计3,439,664,183.613,426,163,996.763,517,413,531.973,431,404,354.44
负债和股东权益合计3,885,168,355.023,919,688,890.453,996,056,318.113,908,493,704.73
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计175,703,267.06915,836,361.4674,682,303.42439,896,855.49
经营活动现金流出小计207,215,474.39743,591,182.91562,965,201.21357,779,454.25
经营活动产生的现金流量净额-31,512,207.33172,245,178.49111,717,102.2182,117,401.24
投资活动现金流入小计171,164,986.291,300,620,310.47964,139,668.82611,185,247.94
投资活动现金流出小计132,522,406.221,499,020,597.18996,664,252.99639,564,676.86
投资活动产生的现金流量净额38,642,580.07-198,400,286.71-32,524,584.17-28,379,428.92
筹资活动现金流入小计39,659,140227,232,614.94170,397,915.6976,005,332.14
筹资活动现金流出小计24,636,813.3235,503,922.34166,522,349.177,675,765.84
筹资活动产生的现金流量净额15,022,326.7-8,271,307.43,875,566.59-1,670,433.7
汇率变动对现金及现金等价物的影响1,218.83-2,816,383.01-2,528,969.64-1,954,548.22
现金及现金等价物净增加额22,153,918.27-37,242,798.6380,539,114.9950,112,990.4
期末现金及现金等价物余额212,131,620.11189,977,701.84307,759,615.46277,333,490.87
最新报告期:2025-04-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中航证券李蔚0.891.131.342025-04-30
太平洋谭紫媚0.941.141.332025-04-29
平安证券叶寅,韩盟盟0.831.111.342025-04-28
首创证券王斌0.911.091.352025-04-28
国盛证券张玉,张金洋,胡偌碧0.871.01--2025-04-13
TOP↑